Weitere Informationen können gerne beim Tumorzentrum Regensburg angefragt werden:


Annika Bohne, Elena Grundler, Helge Knüttel, Alois Fürst, Vinzenz Völkel
Influence of Laparoscopic Surgery on Cellular Immunity in Colorectal Cancer: A Systematic Review and Meta-Analysis
Cancers 2023, 15(13), 3381;

Vinzenz Völkel, Brunhilde Steinger, Michael Koller, Monika Klinkhammer-Schalke & Patricia Lindberg-Scharf
Colorectal cancer survivors’ long-term recollections of their illness and therapy up to seven years after enrolment into a randomised controlled clinical trial.
BMC Cancer 23, 149 (2023).

Maaren MC van, Siesling S, Hueting TA, Völkel V, Hezewijk M van, Strobbe LJ.
The use and misuse of risk prediction tools for clinical decision-making.
The Breast. 2023 Jan 20.

Spoerl S, Erber R, Gerken M, Taxis J, Ludwig N, Nieberle F, Biermann N, Geppert C.I, Ettl T, Hartmann A, Beckhove P, Reichert TE, Spanier G, Spoerl S. A20 as a Potential New Tool in Predicting Recurrence and Patient’s Survival in Oral Squamous Cell Carcinoma.
Cancers 2023 Jan, 15, 675.

Acs M, Gerken M, Schmitt V, Piso P, Königsrainer A, Baransi S, Yurttas C, Häusler S, Horvath P.
Role of HIPEC after Complete Cytoreductive Surgery (CRS) in Peritoneal Recurrence of Platinum-Sensitive Recurrent Ovarian Cancer (OC): The Aim for Standardization at Two Reference Centers for CRS.
Cancers (Basel). 2023 Jan, 7;15(2):405. doi: 10.3390/cancers15020405. PMID: 36672352

Spoerl S, Gerken M, Fischer R, Spoerl S, Kirschneck C, Wolf S, Taxis J, Ludwig N, Biermann N, Reichert TE, Spanier G.
Statin Use Ameliorates Survival in Oral Squamous Cell Carcinoma—Data from a Population-Based Cohort Study Applying Propensity Score Matching
Biomedicines 2023 Jan, 11, 369.

Meyer S, Buser L, Haferkamp S, Berneburg M, Maisch T, Klinkhammer-Schalke M, Pauer A, Vogt T, Garbe C.
Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I-IIA cutaneous melanoma.
Eur J Cancer. 2023 Jan 7;182:77-86. doi: 10.1016/j.ejca.2023.01.002. Online ahead of print. PMID: 36753835


Scheiter A, Hierl F, Lüke F, Keil F, Heudobler D, Einhell S, Klier-Richter M, Konstandin NP, Weber F, Scheiter A, Kandulski A, Schlosser S, Cosma LS, Tews H, Weiss ARR, Grube M, Bumes E, Hau P, Proescholdt M, Steger F, Troeger A, Haferkamp S, Reibenspies LE, Schnabel MJ, Schulz C, Drexler K, Hatzipanagiotou ME, Seitz S, Klinkhammer-Schalke M, Unberath P, Calvisi DF, Pukrop T, Dietmaier W, Evert M, Utpatel K.
Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre.
Br J Cancer. 2022 Dec 26. doi: 10.1038/s41416-022-02120-x. Online ahead of print. PMID: 36572733

Acs M, Gerken M, Zustin J, Blaj S, Isgandarova S, Piso P
Prolonged Survival in Peritoneal Metastatic Appendiceal Carcinoma Patients Treated With Combined Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
J Surg Res 283, 839-852, 2022 Dec

Spoerl S, Gerken M, Schimnitz S, Taxis J, Fischer R, Lindner SR, Ettl T, Ludwig N, Spoerl S, Reichert TE, Spanier G
Prognostic Relevance of Type 2 Diabetes and MetforminTreatment in Head and Neck Melanoma: Results from a Population-Based Cohort Study
Curr Oncol 2022 Dec, 29(12), 9660–9670.

Fernández-Pacheco M, Gerken M, Ortmann O, Ignatov A, Klinkhammer-Schalke M, Hatzipanagiotou ME, Inwald EC.
Impact of cavity shaving on residual tumor rates in patients with primary invasive carcinoma and carcinoma in situ in breast conserving surgery.
Arch Gynecol Obstet. 2022 Oct 25. doi: 10.1007/s00404-022-06803-x. PMID: 36282347

Voelkel, V., Draeger, T., van Mossel, S. et al.
The value of time-dependent risk predictions in a screening context - a comprehensive simulation analysis validated on German cancer registry data.
BMC Med Res Methodol 22, 239 (2022).

Braun R, Klinkhammer-Schalke M, Zeissig SR, Kleihus van Tol K, Bolm L, Honselmann KC, Petrova E, Lapshyn H, Deichmann S, Abdalla TSA, Heckelmann B, Bronsert P, Zemskov S, Hummel R, Keck T, Wellner UF.
Clinical Outcome and Prognostic Factors of Pancreatic Adenosquamous Carcinoma Compared to Ductal Adenocarcinoma-Results from the German Cancer Registry Group.
Cancers (Basel). 2022 Aug 16;14(16):3946. doi: 10.3390/cancers14163946. PMID: 36010939

Scharl S, Sprötge T, Gerken M, Scharl A, Ortmann O, Kölbl O, Klinkhammer-Schalke M, Papathemelis T.
Guideline concordant therapy improves survival in high-grade endometrial cancer patients.
J Cancer Res Clin Oncol. 2022 Oct 14. doi: 10.1007/s00432-022-04318-1. Online ahead of print. PMID: 36239795

Teufel A, Meindl-Beinker NM, Hösel P, Gerken M, Roig A, Ebert MP, Herr W, Scheiter A, Pauer A, Schlitt HJ, Klinkhammer-Schalke M.
Characteristics and outcome of patients with small bowel adenocarcinoma (SBA).
J Cancer Res Clin Oncol. 2022 Sep 26. doi: 10.1007/s00432-022-04344-z. Online ahead of print. PMID: 36163558

Eichberger J, Weber F, Spanier G, Gerken M, Schreml S, Schulz D, Fiedler M, Ludwig N, Bauer RJ, Reichert TE, Ettl T.
Loss of MMP-27 Predicts Mandibular Bone Invasion in Oral Squamous Cell Carcinoma.
Cancers (Basel). 2022 Aug 22;14(16):4044. doi: 10.3390/cancers14164044. PMID: 36011038

Stürzl R, Gerken M, Bruns C, Klinkhammer-Schalke M, Pauer A, Piso P.
Surgical treatment of adenocarcinoma of the esophagogastric junction type II: Comparison between transhiatal extended gastrectomy and thoracoabdominal esophagectomy
Chirurgie (Heidelb). 2022 Aug 20. doi: 10.1007/s00104-022-01703-x. Online ahead of print. PMID: 35987786 German.

Draeger T, Voelkel V, Schreuder K, Veltman J, Dassen A, Strobbe L, Heijmans HJ, Koelemij R, Groothuis-Oudshoorn CGM, Siesling S.
Adherence to the Dutch Breast Cancer Guidelines for Surveillance in Breast Cancer Survivors: Real-World Data from a Pooled Multicenter Analysis.
Oncologist. 2022 Aug 13:oyac126. doi: 10.1093/oncolo/oyac126. Epub ahead of print. PMID: 35962739.

Teufel A, Li M, Gerken M, Ebert MP, Schlitt HJ, Evert M, Herr W, Klinkhammer-Schalke M.
Second Cancer After Additive Chemotherapy in Patients With Colon Cancer.
Clin Colorectal Cancer. 2022 Jul 16:S1533-0028(22)00070-6. doi: 10.1016/j.clcc.2022.07.002. Online ahead of print. PMID: 35934636

Acs M, Gerken M, Gajic I, Mayr M, Zustin J, Piso P.
Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Langenbecks Arch Surg. 2022 Jun 23. doi: 10.1007/s00423-022-02594-6. Online ahead of print. PMID: 35732846

Roessler M, Schmitt J, Bobeth C, Gerken M, Kleihues-van Tol K, Reissfelder C, Rau BM, Distler M, Piso P, Günster C, Klinkhammer-Schalke M, Schoffer O, Bierbaum V.
Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study.
BMC Cancer. 2022 Jun 7;22(1):621. doi: 10.1186/s12885-022-09731-w. PMID: 35672675

Gennari P, Tchaikovski S, Mészáros J, Gerken M, Klinkhammer-Schalke M, Toth G, Ortmann O, Eggemann H, Ignatov A.
Protective effect of pre-operative conization in patients undergoing surgical treatment for early-stage cervical cancer.
Gynecol Oncol. 2022 Jul;166(1):57-60. doi: 10.1016/j.ygyno.2022.05.014. Epub 2022 May 23. PMID: 35618539

Spoerl S, Gerken M, Chamilos C, Spoerl S, Fischer R, Vielsmeier V, Künzel J, Bohr C, Meier JK, Ettl T, Reichert TE, Spanier G.
Clinical significance of panendoscopy in initial staging of oral squamous cell carcinoma and detection of synchronous second malignancies of the upper aerodigestive tract - Insights from a retrospective population-based cohort study.
J Craniomaxillofac Surg. 2022 Jun;50(6):515-522. doi: 10.1016/j.jcms.2022.04.001. Epub 2022 May 2. PMID: 35562318

Fante MA, Felsenstein M, Mayer S, Gerken M, Klinkhammer-Schalke M, Herr W, Vogelhuber M, Reichle A, Heudobler D.
All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma.
Front Oncol. 2022 May 10;12:852987. doi: 10.3389/fonc.2022.852987. eCollection 2022. PMID: 35619924

Filippini Velázquez G, Schiele S, Gerken M, Neumaier S, Hackl C, Mayr P, Klinkhammer-Schalke M, Illerhaus G, Schlitt HJ, Anthuber M, Kröncke T, Messmann H, Märkl B, Schmid C, Trepel M, Müller G, Claus R, Hackanson B.
Predictive preoperative clinical score for patients with liver-only oligometastatic colorectal cancer.
ESMO Open. 2022 Apr 20;7(3):100470. doi: 10.1016/j.esmoop.2022.100470. Online ahead of print. PMID: 35461024

Deichmann S, Dworschak O, Kulemann B, Höppner J, Bolm L, Klinkhammer-Schalke M, Zeissig SR, Kleihus van Tol K, Braun R, Lapshyn H, Keck T, Wellner UF, Honselmann KC.
Incidence, Treatment and Survival in Pancreatic Cancer- Data of the Nationwide Oncological Quality Conference from a Surgical Perspective.
Zentralbl Chir. 2022 Apr;147(2):147-154. doi: 10.1055/a-1768-1012. Epub 2022 Apr 4. PMID: 35378553

Elisabeth C. Inwald, Monika Klinkhammer-Schalke, Jacqueline Müller-Nordhorn, Sven Voigtländer, Michael Gerken, Olaf Ortmann
Auswirkungen der COVID-19-Pandemie auf die Inzidenz und Therapie von Krebserkrankungen
Forum. 2022; 37(3): 198–203. Published online 2022 Apr 1. German. doi: 10.1007/s12312-022-01068-6 PMCID: PMC8972628

Bolm L, Zemskov S, Zeller M, Baba T, Roldan J, Harrison JM, Petruch N, Sato H, Petrova E, Lapshyn H, Braun R, Honselmann KC, Hummel R, Dronov O, Kirichenko AV, Klinkhammer-Schalke M, Kleihues-van Tol K, Zeissig SR, Rades D, Keck T, Fernandez-Del Castillo C, Wellner UF, Wegner RE.
Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Cancer Database (NCDB) and the German Cancer Registry Group of the Society of German Tumor Centers (GCRG/ADT).
Cancers (Basel). 2022 Feb 9;14(4):868. doi: 10.3390/cancers14040868. PMID: 35205616

Spoerl S, Spoerl S, Reil S, Gerken M, Ludwig N, Taxis J, Fischer R, Ettl T, Reichert TE, Spanier G.
Prognostic Value of Perineural Invasion on Survival and Recurrence in Oral Squamous Cell Carcinoma.
Diagnostics (Basel). 2022 Apr 24;12(5):1062. doi: 10.3390/diagnostics12051062. PMID: 35626218

Röhrmoser K, Ignatov A, Gerken M, Ortmann O, Klinkhammer-Schalke M, Papathemelis T.
Risk factors and temporal patterns of recurrences in patients with vulvar cancer: implications for follow-up intervals and duration.
J Cancer Res Clin Oncol. 2022 Feb 18. doi: 10.1007/s00432-022-03954-x. Online ahead of print. PMID: 35179644

Acs M, Halmy L, Isgandarova S, Blaj S, Gerken M, Hormann B, Piso P.
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes Versus 60 Minutes After Cytoreductive Surgery (CRS). Does the 30-Minute Difference Matter? A Comparative Study in a High Volume Centre.
Anticancer Res. 2022 Feb;42(2):1019-1029. doi: 10.21873/anticanres.15563. PMID: 35093903


Voigtländer S, Hakimhashemi A, Inwald EC, Ortmann O, Gerken M, Klug SJ, Klinkhammer-Schalke M, Meyer M, Müller-Nordhorn J.
The Impact of the COVID-19 Pandemic on Cancer Incidence and Treatment by Cancer Stage in Bavaria, Germany.
Dtsch Arztebl Int. 2021 Oct 1;118(39):660-661. doi: 10.3238/arztebl.m2021.0329. PMID: 34919047

Völkel V, Klinkhammer-Schalke M, Fürst A.
Falling Mortality Thanks to Improved Treatment for Colorectal Cancer.
Dtsch Arztebl Int. 2021 Oct 1;118(39):664. doi: 10.3238/arztebl.m2021.0259. PMID: 34919049

Spoerl S, Spanier G, Reiter E, Gerken M, Haferkamp S, Grosse J, Drexler K, Ettl T, Klinkhammer-Schalke M, Fischer R, Spoerl S, Reichert TE, Klingelhöffer C.
Head and neck melanoma: outcome and predictors in a population-based cohort study.
Head Face Med. 2021 Oct 22;17(1):45. doi: 10.1186/s13005-021-00295-x. PMID: 34686191

Völkel, V., Hueting, T.A., Draeger, T. et al.
Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model.
Breast Cancer Res Treat 189, 817–826 (2021).

Sophia Scharl, Tim Sprötge, Michael Gerken, Anton Scharl, Atanas Ignatov, Elisabeth C Inwald, Olaf Ortmann, Oliver Kölbl, Monika Klinkhammer-Schalke, Thomas Papathemelis
Factors influencing treatment decision and guideline conformity in high-grade endometrial cancer patients: a population-based study
Arch Gynecol Obstet. 2021 Jul 5. doi: 10.1007/s00404-021-06140-5. PMID: 34223974

Lindberg-Scharf P, Steinger B, Koller M, Hofstädter A, Ortmann O, Kurz J, Sasse J, Klinkhammer-Schalke M.
Long-term improvement of quality of life in patients with breast cancer: supporting patient-physician communication by an electronic tool for inpatient and outpatient care.
Support Care Cancer. 2021 Jun 27. doi: 10.1007/s00520-021-06270-1. Online ahead of print. PMID: 34176020

Sandra Windschüttl, Tobias Pukrop, Anne Herrmann, Patricia Lindberg-Scharf, Daniel Heudobler, Wolfgang Herr, Reinhard Andreesen, Monika Klinkhammer-Schalke, Michael Koller
Development of a screening workflow to identify patient needs in an interdisciplinary oncological day clinic [article in German]
Z Evid Fortbild Qual Gesundhwes. 2021 Jun;163:30-37. doi: 10.1016/j.zefq.2021.04.004. Epub 2021 May 21.

Scharl S, Gerken M, Sprötge T, Kronberger K, Scharl A, Ignatov A, Ortmann O, Kölbl O, Klinkhammer-Schalke M, Papathemelis T.
Comparison of survival outcomes and effects of therapy between subtypes of high-grade endometrial cancer - a population-based study.
Acta Oncol. 2021 Apr 27:1-7. doi: 10.1080/0284186X.2021.1914347. PMID: 33905297

Till Markowiak, Beshir Dakkak, Elena Loch, Christian Großer, Monika Klinkhammer-Schalke, Hans-Stefan Hofmann, Michael Ried
Video-assisted pulmonary metastectomy is equivalent to thoracotomy regarding resection status and survival
J Cardiothorac Surg . 2021 Apr 15;16(1):84. doi: 10.1186/s13019-021-01460-8. PMID: 33858453

Till Markowiak, Reiner Neu, Mohammed Khalid Afeen Ansari, Christian Großer, Monika Klinkhammer-Schalke, Hans-Stefan Hofmann, Michael Ried
Surgical cytoreduction and HITOC for thymic malignancies with pleural dissemination
Thorac Cardiovasc Surg. 2021 Mar;69(2):157-164. doi: 10.1055/s-0039-1700883. Epub 2019 Nov 15. PMID: 31731316

Hetterich M, Gerken M, Ortmann O, Inwald EC, Klinkhammer-Schalke M, Eggemann H, Ignatov A.
Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases.
Breast Cancer Res Treat. 2021 Mar 15. doi: 10.1007/s10549-021-06162-2. PMID: 33721148

Finke I, Behrens G, Maier W, Schwettmann L, Pritzkuleit R, Holleczek B, Kajüter H, Gerken M, Mattutat J, Emrich K, Jansen L, Brenner H.
Small‐area analysis on socioeconomic inequalities in cancer survival for 25 cancer sites in Germany.
International Journal of Cancer 2021 Mar 09. doi: 10.1002/ijc.33553

Völkel V, Schatz S, Draeger T, Gerken M, Klinkhammer-Schalke M, Fürst A.
Transanal total mesorectal excision: short- and long-term results of the first hundred cases of a certified colorectal cancer center in Germany.
Surg Endosc. 2021 Mar 1. doi: 10.1007/s00464-021-08384-3. Online ahead of print. PMID: 33650009

Scharl S, Becher C, Gerken M, Scharl A, Anapolski M, Ignatov A, Inwald EC, Ortmann O, Kölbl O, Klinkhammer-Schalke M, Papathemelis T.
Is there a benefit for adjuvant radio(chemo)therapy in early cervical cancer? Results from a population-based study.
Arch Gynecol Obstet. 2021 Feb 11. doi: 10.1007/s00404-021-05989-w. PMID: 33575846

Gennari P, Gerken M, Mészáros J, Klinkhammer-Schalke M, Ortmann O, Eggemann H, Ignatov A.
Minimal-invasive or open approach for surgery of early cervical cancer: the treatment center matters.
Arch Gynecol Obstet. 2021 Jan 22. doi: 10.1007/s00404-020-05947-y. PMID: 33483846

Spanier G, Ugele I, Nieberle F, Symeou L, Schmidhofer S, Brand A, Meier J, Spoerl S, Krupar R, Rümmele P, Siska P, Renner K, Peter K, Gerken M, Beckhove P, Reichert TE, Kreutz M, Singer K.
The predictive power of CD3+ T cell infiltration of oral squamous cell tumors is limited to non-diabetic patients.
Cancer Lett. 2020 Dec 1:S0304-3835(20)30628-5. doi: 10.1016/j.canlet.2020.11.029. PMID: 33276040


Tobias Robold, Jakob Neumeier, Michael Ried, Reiner Neu, Zsolt Sziklavari, Christian Grosser, Monika Klinkhammer-Schalke, Hans-Stefan Hofmann
Surgical treatment of lung cancer: how has the introduction of the 8th edition of the TNM classification affected guideline-based therapy? [article in German]
Zentralbl Chir. 2020 Dec;145(6):589-596. doi: 10.1055/a-1164-7058. Epub 2020 Jul 6. PMID: 32629508 doi: 10.1055/a-1164-7058

Staubach P, Scharl A, Ignatov A, Ortmann O, Inwald EC, Hildebrandt T, Gerken M, Klinkhammer-Schalke M, Scharl S, Papathemelis T.
Sentinel lymph node detection by means of indocyanine green using the Karl Storz VITOM® fluorescence camera: a comparison between primary sentinel lymph node biopsy versus sentinel lymph node biopsy after neoadjuvant chemotherapy.
J Cancer Res Clin Oncol. 2020 Nov 23. doi: 10.1007/s00432-020-03461-x. Online ahead of print. PMID: 33230583

Spoerl S, Gerken M, Fischer R, Mamilos A, Spoerl S, Wolf S, Pohl F, Klingelhöffer C, Ettl T, Reichert TE, Spanier G.
Lymphatic and vascular invasion in oral squamous cell carcinoma: Implications for recurrence and survival in a population-based cohort study.
Oral Oncol. 2020 Oct 5;111:105009. doi: 10.1016/j.oraloncology.2020.105009. Online ahead of print. PMID: 3303218

Reinert C, Gerken M, Rathberger K, Krueger K, Klinkhammer-Schalke M, Lindberg-Scharf P, Koelbl O, Proescholdt MA, Riemenschneider MJ, Pukrop T, Bumes E, Hutterer M, Hau P.
Single-institution cross-sectional study to evaluate need for information and need for referral to psychooncology care in association with depression in brain tumor patients and their family caregivers.
BMC Psychol. 2020 Sep 10;8(1):96. doi: 10.1186/s40359-020-00460-y. PMID: 32912313

Völkel, V., Draeger, T., Gerken, M., Klinkhammer-Schalke, M., Benz, S., Fürst, A.
Laparoscopic surgery for colon cancer - A systematic review with special focus on real-world data.
coloproctology (2020) 10. September 2020. doi: 10.1007/s00053-020-00481-6

Hellmund P, Schmitt J, Roessler M, Meier F, Schoffer O.
Targeted and Checkpoint Inhibitor Therapy of Metastatic Malignant Melanoma in Germany, 2000-2016.
Cancers (Basel). 2020 Aug 20;12(9):E2354. doi: 10.3390/cancers12092354. PMID: 32825357
Acknowledgement: Cancer Register of Southwest Saxony, Zwickau, Zwickau, Germany; Clinical Cancer Registry Dresden, Dresden, Germany; Clinical Cancer Registry of the Charité Comprehensive Cancer Center, Berlin, Germany; Klinisches Krebsregister Halle, Halle, Germany; Onkologische Qualitätssicherung (QS) in Westfalen-Lippe, Münster, Germany; Tumour Centre Chemnitz, Chemnitz, Germany; Tumour Centre Erfurt, Erfurt, Germany; Tumour Centre Leipzig, Leipzig, Germany; Tumour Centre Oberfranken, Bayreuth, Germany; Tumour Centre Regensburg, Regensburg, Germany; Tumour Centre Ulm/Comprehensive Cancer Centre Ulm (CCCU), Ulm, Germany; Tumour Centre Wiesbaden, Wiesbaden, Germany.

Teresa Draeger,  Vinzenz Voelkel,  Catharina GM Groothuis-Oudshoorn, Miha Lavric,  Jeroen Veltman, PhD, Anneriet Dassen, Liesbeth, Annemieke Witteveen, Gabe S. Sonke, Hendrik Koffijberg, Sabine Siesling
Applying Risk-Based Follow-Up Strategies on the Dutch Breast Cancer Population: Consequences for Care and Costs.
In: Value in Health, Volume 23, Issue 9, 2020,
Pages 1149-1156, published: August 13, 2020, DOI: 10.1016/j.jval.2020.05.012

Teufel A, Gerken M, Fürst A, Ebert M, Hohenthanner I, Klinkhammer-Schalke M.
Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancer.
Eur J Cancer. 2020 Aug 7;137:148-160. doi: 10.1016/j.ejca.2020.06.036. Online ahead of print. PMID: 32777714

Spoerl S, Gerken M, Mamilos A, Fischer R, Wolf S, Nieberle F, Klingelhöffer C, Meier JK, Spoerl S, Ettl T, Reichert TE, Spanier G.
Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study.
Clin Oral Investig. 2020 Aug 4. doi: 10.1007/s00784-020-03471-6. Online ahead of print. PMID: 32754787

Jansen L, Behrens G, Finke I, Maier W, Gerken M, Pritzkuleit R, Holleczek B, Brenner H; German Cancer Survival Working Group.
Area-Based Socioeconomic Inequalities in Colorectal Cancer Survival in Germany: Investigation Based on Population-Based Clinical Cancer Registration.
Front Oncol. 2020 May 29;10:857. doi: 10.3389/fonc.2020.00857. eCollection 2020. PMID: 32670870

Spanier G, Böttcher J, Gerken M, Fischer R, Roth G, Lehn P, Klingelhöffer C, Meier JK, Fraccaroli A, Tischer J, Ettl T, Klinkhammer-Schalke M, Reichert TE, Spoerl S.
Prognostic value of perioperative red blood cell transfusion and anemia on survival and recurrence in oral squamous cell carcinoma.
Oral Oncol. 2020 May 7;107:104773. doi: 10.1016/j.oraloncology.2020.104773. PMID:32388408

Prantl L, Gerken M, Zeman F, Leitzmann M, Koller M, Klinkhammer-Schalke M, Evert M, Kuehlmann B, Biermann N
Incidence of Anaplastic Large Cell Lymphoma and Breast-Implant-Associated Lymphoma—An Analysis of a Certified Tumor Registry over 17 Years
J. Clin. Med. April, 2020, 9, 1247; doi: 10.3390/jcm9051247

Klinkhammer-Schalke M, Steinger B, Koller M, Zeman F, Fürst A, Gumpp J, Obermaier R, Piso P, Lindberg-Scharf P; Regensburg QoL Study Group.
Diagnosing deficits in quality of life and providing tailored therapeutic options: Results of a randomised trial in 220 patients with colorectal cancer.
Eur J Cancer. 2020 Mar 13;130:102-113. doi: 10.1016/j.ejca.2020.01.025. [Epub ahead of print] PMID:32179445

Papathemelis T, Scharl A, Anapolski M, C Inwald E, Ignatov A, Ortmann O, Gerken M, Klinkhammer-Schalke M, Scharl S.
Value of indocyanine green pelvic lymph node mapping in the surgical approach of cervical cancer.
Arch Gynecol Obstet. 2020 Feb 11. doi: 10.1007/s00404-020-05457-x. [Epub ahead of print] PMID: 32048031

Finke I, Behrens G, Schwettmann L, Gerken M, Pritzkuleit R, Holleczek B, Brenner H, Jansen L; German Cancer Survival Working Group.
Socioeconomic differences and lung cancer survival in Germany: Investigation based on population-based clinical cancer registration.
Lung Cancer. 2020 Feb 4;142:1-8. doi: 10.1016/j.lungcan.2020.01.021. [Epub ahead of print] PMID: 32044589

Schmuck R, Gerken M, Teegen EM, Krebs I, Klinkhammer-Schalke M, Aigner F, Pratschke J, Rau B, Benz S.
Gender comparison of clinical, histopathological, therapeutic and outcome factors in 185,967 colon cancer patients.
Langenbecks Arch Surg. 2020 Jan 31. doi: 10.1007/s00423-019-01850-6. [Epub ahead of print] PMID:32002628

Papathemelis T, Oppermann H, Grafl S, Gerken M, Pauer A, Scharl S, Scharl A, Inwald E, Ignatov A, Ortmann O, Klinkhammer-Schalke M, Hein A, Beckmann MW, Lux MP (2020).
Long-term outcome of patients with intermediate- and high-risk endometrial cancer after pelvic and paraaortic lymph node dissection: a comparison of laparoscopic vs. open procedure.
J Cancer Res Clin Oncol. 2020 Jan 4. doi: 10.1007/s00432-019-03122-8. [Epub ahead of print] PMID: 31901975


Fiedler M, Renner P, Schubert J, Weber F, Hartmann A, Iro H, Vielsmeier V, Bohr C, Gerken M, Reichert TE, Ettl T.
Predictive value of FHIT, p27, and pERK1/ERK2 in salivary gland carcinomas: a retrospective study.
Clin Oral Investig. 2019 Oct;23(10):3801-3809. doi: 10.1007/s00784-019-02809-z. Epub 2019 Jan 23. PMID: 30673867

Taubenhansl C, Ortmann O, Gerken M, Inwald EC, Klinkhammer-Schalke M (2019).
Guideline-concordant chemotherapy in patients with hormone receptor-positive and node-positive, early breast cancer leads to better overall and metastases-free survival with limited benefit in elderly patients.
Arch Gynecol Obstet. 2019 Nov 20. doi: 10.1007/s00404-019-05387-3. PMID: 1749031

Schnitzbauer V, Gerken M, Benz S, Völkel V, Draeger T, Fürst A, Klinkhammer-Schalke M. (2019) Laparoscopic and open surgery in rectal cancer patients in Germany: short and long-term results of a large 10-year population-based cohort. Surg Endosc. 2019 May 30. doi: 10.1007/s00464-019-06861-4. PMID: 31147825

Völkel V, Draeger T, Schnitzbauer V, Gerken M, Benz S, Klinkhammer-Schalke M, Fürst A. (2019) Surgical treatment of rectal cancer patients aged 80 years and older-a German nationwide analysis comparing short- and long-term survival after laparoscopic and open tumor resection. Eur J Surg Oncol. 2019 May 9. pii: S0748-7983(19)30443-3. doi:10.1016/j.ejso.2019.05.005. [Epub ahead of print] PMID: 31092363

Voelkel V, Draeger T, Groothuis-Oudshoorn CGM, de Munck L, Hueting T, Gerken M, Klinkhammer-Schalke M, Lavric M, Siesling S. (2019) Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany. J Cancer Res Clin Oncol. 2019 Mar 29. doi: 10.1007/s00432-019-02904-4. [Epub ahead of print] PMID: 30927074

Papathemelis T, Knobloch S, Gerken M, Scharl A, Anapolski M, Ignatov A, Inwald EC, Ortmann O, Scharl S, Klinkhammer-Schalke M. (2019) Impact of nodal status and treatment strategy on overall survival in advanced stage cervical cancer. J Cancer Res Clin Oncol. 2019 Mar 18. doi: 10.1007/s00432-019-02890-7

Draeger T, Völkel V, Schnitzbauer V, Gerken M, Benz S, Klinkhammer-Schalke M, Fürst A. (2019) Laparoscopic and open resection of rectal cancer-is age an effect modifier for short- and long-term survival? Int J Colorectal Dis. 2019 Feb 18. doi: 10.1007/s00384-019-03265-7. [Epub ahead of print] PMID: 30778670

Wimmer T, Ortmann O, Gerken M, Klinkhammer-Schalke M, Koelbl O, Inwald EC. (2019) Adherence to guidelines and benefit of adjuvant radiotherapy in patients with invasive breast cancer: results from a large population-based cohort study of a cancer registry. Arch Gynecol Obstet. 2019 Jan 4. [Epub ahead of print] PMID: 30607594


Seliger C, Schaertl J, Gerken M, Luber C, Proescholdt M, Riemenschneider MJ, Leitzmann MF, Hau P, Klinkhammer-Schalke M. (2018) Use of statins or NSAIDs and survival of patients with high-grade glioma.
Int J Colorectal Dis. 2018 Aug 21. PLoS ONE 2018 Dec 13(12): e0207858.

Piso P, Stierstorfer K, Gerken M, Klinkhammer-Schalke M.(2018) Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer.
Int J Colorectal Dis. 2018 Aug 21. [Epub ahead of print] PMID:30132068

Seliger C, Luber C, Gerken M, Schaertl J, Proescholdt M, Riemenschneider MJ, Meier CR, Bogdahn U, Leitzmann MF, Klinkhammer-Schalke M, Hau P. (2018) Use of metformin and survival of patients with high-grade glioma. Int J Cancer. 2018 Aug 9. doi: 10.1002/ijc.31783 [Epub ahead of print] PMID:30091464

Papathemelis T, Hassas D, Gerken M, Klinkhammer-Schalke M, Scharl A, Lux MP, Beckmann MW, Scharl S. (2018) Is there a benefit of lymphadenectomy for overall and recurrence-free survival in type I FIGO IB G1-2 endometrial carcinoma? A retrospective population-based cohort analysis. J Cancer Res Clin Oncol. 2018 Jul 23. doi: 10.1007/s00432-018-2715-4 [Epub ahead of print] PMID: 30039227

Ott C, Gerken M, Hirsch D, Fest P, Fichtner-Feigl S, Munker S, Schnoy E, Stroszczynski C, Vogelhuber M, Herr W, Evert M, Reng M, Schlitt HJ, Klinkhammer-Schalke M, Teufel A. (2018) Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment. Digestion. 2018 Jun 5;98(3):143-152. doi: 10.1159/000487710 PMID: 29870979

Munker S, Gerken M, Fest P, Ott C, Schnoy E, Fichtner-Feigl S, Wiggermann P, Vogelhuber M, Herr W, Stroszczynski C, Schlitt HJ, Evert M, Reng M, Klinkhammer-Schalke M, Teufel A. (2018) Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects. BMC Cancer. 2018 Apr 23;18(1):455. doi: 10.1186/s12885-018-4380-z PMID: 29685155

Völkel V, Draeger T, Gerken M, Fürst A, Klinkhammer-Schalke M.(2018) Langzeitüberleben von Patienten mit Kolon- und Rektumkarzinomen: Ein Vergleich von Darmkrebszentren und nicht zertifizierten Krankenhäusern - [Long-Term Survival of Patients with Colon and Rectum Carcinomas: Is There a Difference Between Cancer Centers and Non-Certified Hospitals?]. Gesundheitswesen. 2018 Apr 19. doi: 10.1055/a-0591-3827 PMID: 29672814

Draeger T, Völkel V, Gerken M, Klinkhammer-Schalke M, Fürst A (2018). Long-term oncologic outcomes after laparoscopic versus open rectal cancer resection: a high-quality population-based analysis in a Southern German district. Surg Endosc. 2018 Apr 2. doi: 10.1007/s00464-018-6148-6. PMID: 29611044

Völkel V, Draeger T, Gerken M, Klinkhammer-Schalke M, Fürst A (2018). Long-term oncologic outcomes after laparoscopic vs. open colon cancer resection: a high-quality population-based analysis in a Southern German district. Surg Endosc. 2018 Mar 30. doi: 10.1007/s00464-018-6158-4. PMID: 29602999

Reinert C, Rathberger K, Klinkhammer-Schalke M, Kölbl O, Proescholdt M, Riemenschneider MJ, Schuierer G, Hutterer M, Gerken M, Hau P (2018). Information needs and requirements in patients with brain tumours and their relatives. J Neurooncol 2018 Mar 7. PMID: 29516343

Liebig-Hörl G, Puchner C, Gerken M, Klinkhammer-Schalke M, Fürst A (2018). Therapeutische Strategie bei Frühkarzinom im Rektum (T1-Karzinom) [Treatment strategy for early stage rectal cancer (T1 carcinoma)]. Chirurg 2018 Feb 14 doi: 10.1007/s00104-018-0603-8  PMID: 29445855

Papathemelis Th, Jablonsky E, Hauzenberger T, Scharl A, Gerken M, Klinkhammer-Schalke M, Hipp M, Scharl S (2018). Sentinel lymph node biopsy (SLNB) in breast cancer patients by means of indocyanine green (ICG) using the Karl Storz VITOM fluorescence camera. BioMed Research International Volume 2018 (2018),

Scharl S, Papathemelis T, Kronberger K, Gerken M, Scharl A, Kölbl O, Klinkhammer-Schalke M (2018). Does post-operative radiochemotherapy improve survival in high-grade endometrial cancer patients? Results of a population-based cohort analysis of a cancer registry. Arch Gynecol Obstet. 2018 Feb 7. doi: 10.1007/s00404-018-4708-6. [Epub ahead of print]


Haj A, Doenitz Ch, Schebesch KM, Ehrensberger D, Hau P, Putnik K, Riemenschneider MJ, Wendl Ch, Gerken M, Pukrop T, Brawanski A, Proescholdt MA (2017). Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center. Brain Sci. 2018, 8, 5;, PMID: 29295569

Papathemelis T, Scharl S, Kronberger K, Gerken M, Scharl A, Pauer A, Klinkhammer-Schalke M (2017). Survival benefit of pelvic and paraaortic lymphadenectomy in high‑grade endometrial carcinoma: a retrospective population‑based cohort analysis. J Cancer Res Clin Oncol, pp 1–8., PMID: 28840384

Klinkhammer-Schalke M, Steinger B, Koller M, Lindberg P (2017). Lebensqualitätsinterventionen in der Onkologie. Z. Evid. Fortbild. Qual. Gesundh. wesen (ZEFQ).

Lindberg P, Netter P, Koller M, Steinger B, Klinkhammer-Schalke M (2017). Breast cancer survivors` recollection of their quality of life: identifying determinants of recall bias in a longitudinal population-based trial. PLoS ONE.

Inwald EC, Ortmann O, Koller M, Zeman F, Hofstädter F, Evert M, Brockhoff G, Klinkhammer-Schalke M (2017). Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology. Breast Cancer Res Treat, 163:119-130.

Klinkhammer-Schalke M, Gerken M, Barlag H, Hofstädter F, Benz S (2017). Bedeutung von Krebsregistern für die Versorgungsforschung - Registerstudien vs. klinische Studien am Beispiel des Kolonkarzinoms. Onkologe, 23:280-287.


Benz S, Barlag H, Gerken M, Fürst, Klinkhammer-Schalke M (2016). Laparoscopic surgery in patients with colon cancer: a population-based analysis. Surg Endosc, 31:2586-2595.

Schoffer O, Schülein S, Arand G, Arnholdt H, Baaske D, Bargou RC, Becker N, Beckmann MW, Bodack Y, Böhme B, Bozkurt T, Breitsprecher R, Buchali A, Burger E, Burger U, Dommisch K, Elsner G, Fernschild K, Flintzer U, Funke U, Gerken M, Göbel H, Grobe N, Gumpp V, Heinzerling L, Kempfer LR, Kiani A, Klinkhammer-Schalke M, Klöcking S, Kreibich U, Knabner K, Kuhn P, Lutze S, Mäder U, Maisel T, Maschke J, Middeke M, Neubauer A, Niedostatek A, Opazo-Saez A, Peters C, Schell B, Schenkirsch G, Schmalenberg H, Schmidt P, Schneider C, Schubotz B, Seide A, Strecker P, Taubenheim S, Wackes M, Weiß S, Welke C, Werner C, Wittekind C, Wulff J, Zettl H, Klug SJ (2016). Tumour stage distribution and survival of malignant melanoma in Germany 2002–2011. BMC Cancer, 16:936.

Ettl T, El-Gindi A, Hautmann M, Gosau M, Weber F, Rohrmeier C, Gerken M, Müller S, Reichert T, Klingelhöffer C (2016). Positive frozen section margins predict local recurrence in R0-resected squamous cell carcinoma of the head and neck. Oral Oncology, 55:17–23.

Nemec W, Inwald EC, Buchholz S, Klinkhammer Schalke M, Gerken M, Ortmann O (2016). Effects of morcellation on long-term outcomes in patients with uterine leiomyosarcoma. Arch Gynecol Obstet, 294:825-831.

Ach T, Schwarz-Furlan S, Ach S, Agaimy A, Gerken M, Rohrmeier C, Zenk J, Iro H, Brockhoff G, Ettl T (2016). Genomic aberrations of MDM2, MDM4, FGFR1 and FGFR3 are associated with poor outcome in patients with salivary gland cancer. J Oral Pathol Med, 45:500-509.

Klinkhammer-Schalke M, Gerken M, Barlag H, Teufel A (2016). Nutzung von Krebsregisterdaten zur Messung der Qualität in der klinischen Onkologie und für Versorgungsforschung. Onkologe, 22:192-197.

Klinkhammer-Schalke M, Hofstädter F, Gerken M, Benz S (2016). Der Beitrag Klinischer Krebsregister für die Nutzenbewertung - Anforderungen und erste Ergebnisse? Z. Evid. Fortbild. Qual. Gesundh. wesen (ZEFQ), 112S:S3-S10.

van Oorschot B, Jürgens P, Eschbach C, Ruellan A, Gerken M (2016). Behandlungsbelastung am Lebensende bei Lungenkrebspatienten - Einfluss von unterschiedlichen tumorspezifischen Maßnahmen und unterschiedlichen Gruppendefinitionen auf die Beurteilung der Qualität. Onkologe, 22:673-681.

Benz S, Klinkhammer-Schalke M (2016). Verbessert die Zentrenbildung die klinische Versorgungsqualität? Onkologe, 22:167-176.


Klinkhammer-Schalke M, Lindberg P, Koller M, Wyatt JC, Hofstädter F, Lorenz W, Steinger B (2015). Direct improvement of quality of life in colorectal cancer patients using a tailored pathway with quality of life diagnosis and therapy (DIQOL): study protocol for a randomised controlled trial. Trials, 16:460.

Teufel A, Gerken M, Hartl J, Itzel T, Fichtner-Feigl S, Stroszczynski C, Schlitt HJ, Hofstädter F, Klinkhammer-Schalke M (2015). Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer. BMC Cancer, 15:419.

Inwald EC, Koller M, Klinkhammer-Schalke M, Zeman F, Hofstädter F, Gerstenhauer M, Brockhoff G, Ortmann O (2015). 4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival. Breast Cancer Res Treat, 153:647-658.

Lindberg P, Koller M, Steinger B, Lorenz W, Wyatt JC, Inwald EC, Klinkhammer-Schalke M (2015). Breast cancer survivors’ recollection of their illness and therapy seven years after enrolment into a randomised controlled clinical trial. BMC Cancer, 15:554.

Inwald EC, Koller M, Klinkhammer-Schalke M, Zeman F, Hofstädter F, Lindberg P, Gerstenhauer M, Ortmann O (2015). Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor positive breast cancer - results from a large population-based cohort of a cancer registry. J Cancer Res Clin Oncol, 141:2229-2240.

Klinkhammer-Schalke M, Gerken M, Barlag H, Tillack A (2015). Was können Klinische Krebsregister in Zukunft für die bevölkerungsbezogene Umsetzung evidenzbasierter Leitlinien leisten?
Z. Evid. Fortbild. Qual. Gesundh. wesen (ZEFQ), 109:452-458.

Schüller M, Gosau M, Müller S, Gerken M, Rohrmeier C, Legal S, Schreml S, Ettl T (2015). Long-term outcome and subjective quality of life after surgical treatment of lower lip cancer. Clin Oral Investig, 19:1093-1099.


Klinkhammer-Schalke M, Lindberg P, Koller M, Steinger B, Ortmann O, Hofstädter A, Scharl A, Inwald EC, Lorenz W (2014). Lebensqualität bei Brustkrebs-Patientinnen-Implementierung und Umsetzung in die Routineversorgung. Zeitschrift des Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e.V. (DGGG), Geburtsh Frauenheilk, 74:531-534.

Hackl C, Neumann P, Gerken M, Loss M, Klinkhammer-Schalke M, Schlitt HJ (2014). Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma.
BMC Cancer, 14:810.

Glockzin G, Gerken M, Lang SA, Klinkhammer-Schalke M, Piso P, Schlitt HJ (2014). Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis. BMC Cancer, 14:807.

Ortmann O, Buchholz S, Klinkhammer-Schalke M (2014). Der Nationale Krebsplan - Ziele, Umsetzung und Konsequenzen. Zeitschrift für den Chirurgen "Chirurgische Praxis", Juni 2014 78/Heft 1

Inwald EC, Ortmann O, Zeman F, Koller M, Hofstädter F, Gerstenhauer M, Klinkhammer-Schalke M (2014). Guideline concordant therapy prolongs survival in HER2-positive breast cancer patients: results from a large population-based cohort of a cancer registry. BioMed Research International, Article ID 137304.

Lange R, Matthes C, Schmieder G, Schubotz B,  Wohlgemuth J, Wulff J, Wulff V (2014). Fit für die Umsetzung des Krebsfrüherkennungs- und -registergesetzes? Mitteilungsblatt der Sächsischen Krebsgesellschaft e.V., Ausgabe 2/2014


Lindberg P, Koller M, Steinger B, Lorenz W, Klinkhammer-Schalke M (2013). Lebensqualität: vom Schlagwort zur integrierten Patientenversorgung. Forum, 28:29-34.

Agha A, Benseler V, Hornung M, Gerken M, Iesalnieks I, Fürst A, Anthuber M, Jauch KW, Schlitt HJ (2013). Long-term oncologic outcome after laparoscopic surgery for rectal cancer. Surg Endosc., 28(4):1119-1125.

Inwald EC, Klinkhammer-Schalke M, Hofstädter F, Zeman F, Koller M, Gerstenhauer M, Ortmann O (2013). Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry.
Breast Cancer Res Treat, 139(2):539–552.

Klinkhammer-Schalke M und Katalinic A (2013). Der Nationale Krebsplan aus Sicht der klinischen und epidemiologischen Register. mdi, Forum der Medizin Dokumentation und Medizin Informatik, Heft 2, Juni 2013

Ried M, Speth U, Potzger T, Neu R, Diez C, Klinkhammer-Schalke M, Hofmann HS (2013). Regionale Versorgung des malignen Pleuramesothelioms. Ergebnisse aus dem Tumorzentrum Regensburg.
Zeitschrift Chirurg, 84(11):987–993.

Schrodi S, Braisch U, Schenkirsch G, Maisel T, Petsch S, Hölzl D, Klinkhammer-Schalke M, Mäder U, Schuller L, Heywang-Köbrunner S.H, Meyer M, Engel J (2013). Changes in therapy for breast cancer patients as a result of mammography screening. An analysis of Bavarian cancer registry data from 2000 to 2008. Gesundheitswesen 2013, 75(10):632-642.


Klinkhammer-Schalke M, Koller M, Steinger B, Ehret C, Ernst B, Wyatt JC, Hofstaedter F, Lorenz W (2012). Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer. Br J Cancer, 106:826-838.

Klinkhammer-Schalke M, Marschner N, Hofstädter F (2012). Register in der onkologischen Versorgungsforschung.
Beitrag, Der Onkologe, 18(2):142–150.

Wittekind C, Hofstädter F (2012). Optimale Zusammenarbeit von Klinikern und Pathologen in der Tumordiagnostik.
Forum, 27(1):54–58.

Blum T, Schönfeld N, Jagota A, Klinkhammer-Schalke M (2012). Integration und Steuerfunktion klinischer Krebsregister in der onkologischen Versorgung. Forum, 27(6):431-435.

Krause S.W, Gerken M, Andreesen R, Hofstädter F, Klinkhammer-Schalke M (2012). Treatment of B-cell lymphoma with chemotherapy plus rituximab: a survival benefit can be demonstrated in the routine data of a regional cancer registry. Annals of Hematology, 91(4):561–570.


Zitzler N, Schulz C, Hofmann HS, Hipp M, Bohrer T, Lindberg P, Klinkhammer-Schalke M, Pfeifer M, Wiese C, Hjermstad MJ, Pompili C, M. Koller M für die EORTC QLG Arbeitsgruppe Lungenkarzinom (2011). Messung der Lebensqualität bei Patienten mit Lungenkarzinom: Aktualisierung des Fragebogenmoduls EORTC QLQ-LC13. Deutsche Zeitschrift für Onkologie, 41:154-159.

Pfaff H, Abholz H, Glaeske G, Icks A, Klinkhammer-Schalke M, Nellessen-Martens G, Neugebauer E.A.M, Ohmann C, Schrappe M, Selbmann H.K, Stemmer R (2011). Health services research: essential for allocation decisions – joint statement. Dtsch med Wochenschr, 136(48):2496-2500.

Mathers M.J, Roth S, Klinkhammer-Schalke M, Gerken M, Hofstädter F, Wilm S, Klotz T (2011). Patients with localized prostate cancer (T1-T2) show improved overall long-term survival compared to the normal population. J Cancer, 2:76–80. PMCID: PMC3039224, PMID: 21326628 [PubMed]

Hackl C, Gerken M, Loss M, Klinkhammer-Schalke M, Piso P, Schlitt H.J (2011). A population-based analysis on the rate and surgical management of colorectal liver metastases in Southern Germany. Int J Colorectal Dis, 26(11):1475-1481. http:\\

Hofstädter F, Klinkhammer-Schalke M (2011). Aufgaben und Strukturen für die klinische Krebsregsistrierung.
Onkologe, 17(2):121-125. http:\\


Klinkhammer-Schalke M, Wesselmann S (2010). Status quo der Zusammenarbeit von Klinischen Krebsregistern und Organkrebszentren. Artikel, Forum 04.2010

Klotz T, Mathers J.M, Gerken M, Klinkhammer-Schalke M, Hofstädter F (2010). Social gradient of PSA screening? 8 years follow up from the cancer registry of the tumor center in Regensburg. Urologe, 49:1503-1507.

Meyer S, Wild PJ, Vogt T, Bataille F, Ehret C, Gantner S, Landthaler M, Klinkhammer-Schalke M, Hofstaedter F, Bosserhoff AK (2010). Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma. Exp Dermatol 19(8):251-257.

Schimanski S, Wild PJ, Treeck O, Horn F, Sigruener A, Rudolph C, Blaszyk H, Klinkhammer-Schalke M, Ortmann O, Hartmann H, Schmitz G (2010). Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissue. Horm Metab Res, 42(2):102-109


Klinkhammer-Schalke M (2009). Kombination von medizinischen und hermeneutischen Ergebnissen in der Versorgungsforschung. Forum, 24:36-43.

Meyer M, Opitz T, Caselmann WH, Schenkirsch G, Maisel T, Petsch S, Engel J, Schubert-Fritschle G, Klinkhammer-Schalke M, Mäder U, Göbel-Lissowsky M, Hölzel D (2009). Ten Years of Epidemiological Cancer Registration in Bavaria. Gesundheitswesen, 71(5):293-298.

Ruemmele P, Dietmaier W, Terracciano L, Tornillo L, Bataille F, Kaiser A, Wuensch PH, Heinmoeller E, Homayounfar K, Luettges J, Kloeppel G, Sessa F, Edmonston TB, Schneider-Stock R, Klinkhammer-Schalke M, Pauer A, Schick S, Hofstaedter F, Baumhoer D, Hartmann A (2009). Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions. Am J Surg Pathol, 33(5):691-704. PMID:19252434


Klinkhammer-Schalke M, Koller M, Steinger B, Ehret C, Ernst B, Wyatt J, Hofstaedter F, Lorenz W (2008). Implementing a system of quality of life diagnosis and therapy for breast cancer patients: Results of an exploratory trial as prerequisite for a subsequent RCT. Br J Cancer, 99:415-422.

Klinkhammer-Schalke M, Koller M, Wyatt J, Steinger B, Ehret C, Ernst B, Hofstaedter F, Lorenz W (2008). Quality of life diagnosis and therapy as complex intervention for improvement of health in breast cancer patients: delineating the conceptual, methodological, and logistic requirements (modeling). Langenbecks Arch Surg, 393:1.

Koch H, Hau P, Klinkhammer-Schalke M (2008). Alter, Geschlecht und Karnofsky-Index als Prognosefaktoren bei malignen Hirntumoren Grad III und IV WHO. European Journal of Geriatrics 10:69-73.

Iesalnieks I, Winter H, Bareck E, Sotiropoulos GC, Goretzki PE, Klinkhammer-Schalke M, Bröckner S, Trupka A, Anthuber M, Rupprecht H, Raab M, Meyer W, Reichmann F, Kästel M, Mayr M, Braun W, Schlitt HJ, Agha A (2008). Thyroid metastases of renal cell carcinoma: clinical course in 45 patients undergoing surgery. Assessment of factors affecting patients' survival. Thyroid, 18(6):615-624.

Mathers MJ, Zumbe J, Wyler S, Roth S, Gerken M, Hofstädter F, Klotz T (2008). Is there evidence for a multidisciplinary follow-up after urological cancer? An evaluation of subsequent cancers. World J Urol. 26(3):251-6.